Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Sleep Med. 2023 Jul 13;109:211–218. doi: 10.1016/j.sleep.2023.07.009

Table 2.

Differences in the 1-year OSA treatment pathways by insurance provider (n=31,585)

Percentage of patients on each treatment pathway Odds ratio for likelihood of each treatment pathway in Medicaid patients (ref: Commercial)+
All Commercial Medicaid OR 95% CI
(1) Surgical care + PSG 11.4% 11.3% 11.7% 1.02 .95, 1.09
(2) Surgical care only 31.8% 30.6% 32.9% 1.21 1.15, 1.28
(3) PSG + specialty care 5.9% 8.0% 4.5% .52 .47, 57
(4) PSG only 6.4% 5.0% 7.3% 1.46 1.32, 1.61
(5) Specialty care only 6.1% 8.1% 4.7% .57 .52, .63
(6) PAP care 3.4% 4.0% 3.1% .68 .59, .77
(7) No care 34.4% 33.0% 35.8% 1.13 1.07, 1.18
(8) Comprehensive care 0.6% -- -- -- --

PAP=positive airway pressure; PSG=polysomnography.

+

Binomial logistic regression models after adjusting for child gender, age, any complex chronic conditions, and obesity during 1-year prior to and at time of OSA diagnosis. Bold indicates significant associations (p<0.05).

(1)

PSG + surgical care: Any PSG prior to, at the time of, or post-OSA diagnosis plus surgical care (adenotonsillectomy, tonsillectomy, adenoidectomy).

(2)

Surgical care only: Surgical care without any PSG history.

(3)

PSG + specialty care: Any PSG prior to, at the time of, or post-OSA diagnosis plus pulmonary and/or otolaryngology visits.

(4)

PSG only: Any PSG prior to, at the time of, or post-OSA diagnosis with no surgical care, no PAP, and no specialty care.

(5)

Specialty care only: Pulmonary and/or otolaryngology visits only with no PSG, no surgical care, and no PAP.

(6)

PAP care: PAP prescription and/or PSG with PAP titration.

(7)

No treatment: No PSG history, surgical care, specialty care, or PAP care.

(8)

Comprehensive care: Excluded due to small sample size (n=202) and high utilization of OSA-related care (i.e., surgical care, PAP, and/or PSG, and/or specialty care).